These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8631024)

  • 1. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
    Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S
    Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients.
    Pandis N; Teixeira MR; Adeyinka A; Rizou H; Bardi G; Mertens F; Andersen JA; Bondeson L; Sfikas K; Qvist H; Apostolikas N; Mitelman F; Heim S
    Genes Chromosomes Cancer; 1998 Jun; 22(2):122-9. PubMed ID: 9598799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells.
    Zhang R; Wiley J; Howard SP; Meisner LF; Gould MN
    Cancer Res; 1989 Jan; 49(2):444-9. PubMed ID: 2910462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
    Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumorous samples from 3 patients.
    Teixeira MR; Pandis N; Bardi G; Andersen JA; Mitelman F; Heim S
    Int J Cancer; 1995 Sep; 63(1):63-8. PubMed ID: 7558454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic findings in ductal carcinoma of the breast].
    Rojas-Atencio A; González L; Urdaneta K; Soto-Alvarez M; Prieto-Carrasquero M; Fulcado W; Quintero M; Boscán A; Alvarez Nava F
    Invest Clin; 1999 Sep; 40(3):179-89. PubMed ID: 10531751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
    Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different cytogenetic patterns in skeletal breast cancer metastases.
    Adeyinka A; Pandis N; Nilsson J; Idvall I; Mertens F; Petersson C; Heim S; Mitelman F
    Genes Chromosomes Cancer; 1996 May; 16(1):72-4. PubMed ID: 9162201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic polyclonality of breast carcinomas: association with clinico-pathological characteristics and outcome.
    Steinarsdottir M; Gudmundsson IH; Jonasson JG; Olafsdottir EJ; Eyfjörd JE; Ogmundsdottir HM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):930-9. PubMed ID: 21910159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
    Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
    Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
    Bonsing BA; Devilee P; Cleton-Jansen AM; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
    Cancer Res; 1993 Aug; 53(16):3804-11. PubMed ID: 8101767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic changes in nonmalignant breast tissue.
    Steinarsdóttir M; Jónasson JG; Vidarsson H; Júlíusdóttir H; Hauksdóttir H; Ogmundsdóttir HM
    Genes Chromosomes Cancer; 2004 Sep; 41(1):47-55. PubMed ID: 15236316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin.
    Teixeira MR; Qvist H; Bøhler PJ; Pandis N; Heim S
    Genes Chromosomes Cancer; 1998 Jun; 22(2):145-51. PubMed ID: 9598802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic characterization of tumors of the vulva and vagina.
    Micci F; Teixeira MR; Scheistrøen M; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2003 Oct; 38(2):137-48. PubMed ID: 12939741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome alterations associated with positive and negative lymph node involvement in breast cancer.
    Wuicik L; Cavalli LR; Cornélio DA; Schmid Braz AT; Barbosa ML; Lima RS; Urban CA; Bleggi Torres LF; Ribeiro EM; Cavalli IJ
    Cancer Genet Cytogenet; 2007 Mar; 173(2):114-21. PubMed ID: 17321326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.